1
|
Munir K, Oner O, Kerala C, Rustamov I, Boztas H, Juszkiewicz K, Wloszczak-Szubzda A, Kalmatayeva Z, Iskandarova A, Zeynalli S, Cibrev D, Kosherbayeva L, Miriyeva N, Jarosz MJ, Kurakbayev K, Soroka E, Mancevska S, Novruzova N, Emin M, Olajossy M, Bajraktarov S, Raleva M, Roy A, Waqar Azeem M, Bertelli M, Salvador-Carulla L, Javed A. Social distance and stigma towards persons with serious mental illness among medical students in five European Central Asia countries. Psychiatry Res 2022; 309:114409. [PMID: 35121341 DOI: 10.1016/j.psychres.2022.114409] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/17/2021] [Revised: 01/18/2022] [Accepted: 01/20/2022] [Indexed: 02/02/2023]
Abstract
The study investigated behavioral measures of social distance (i.e., desired proximity between self and others in social contexts) as an index of stigma against those with mental illness among medical students in the Republic of North Macedonia, Turkey, Azerbaijan, Kazakhstan, and Poland, using the Reported and Intended Behavior Scale (RIBS), a standardized, self-administered behavioral measure based on the Star Social Distance Scale. The students' responses to standardized clinical vignettes on schizophrenia, and depression with suicidal ideation, were also assessed. A total of 257 North Macedonian (females, 31.5%; 1-4 grades, 189; 5-6 grades, 68); 268 Turkish (females, 43.3%; 1-4 grades, 90; 5-6 grades, 178); 450 Kazakh (females, 28.4%, 71.6%; 1-4 grades, 312; 5-6 grades, 138); 512 Azerbaijani (females, 24%; 1-4 grades, 468; 5-6 grades, 44; females, 24%), and 317 Polish (females, 59.0%; 1-4 grades, 208; 5-6 grades, 109) students were surveyed. The responses on the RIBS social distance behavior measures did not improve with advancing medical school grade, but students across all sites viewed schizophrenia and depression as real medical illnesses. The results support the development of enhanced range of integrated training opportunities for medical student to socially interact with persons with mental illness sharing their experiences with them.
Collapse
Affiliation(s)
- Kerim Munir
- Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA; World Psychiatric Association, Geneva, Switzerland.
| | - Ozgur Oner
- World Psychiatric Association, Geneva, Switzerland; Bahcesehir University School of Medicine, Istanbul, Turkey
| | - Coskun Kerala
- Faculty of Medicine, Ss. Cyril and Methodius University, Skopje, Republic of North Macedonia
| | | | | | - Konrad Juszkiewicz
- Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan; Al-Farabi Kazakh National Medical University, Almaty, Kazakhstan
| | | | | | | | | | - Dragan Cibrev
- Faculty of Medicine, Ss. Cyril and Methodius University, Skopje, Republic of North Macedonia
| | - Lyazzat Kosherbayeva
- Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan; Al-Farabi Kazakh National Medical University, Almaty, Kazakhstan
| | | | | | | | | | - Sanja Mancevska
- Faculty of Human Sciences, University of Economics and Innovation, Lublin, Poland
| | | | - Melda Emin
- Faculty of Medicine, Ss. Cyril and Methodius University, Skopje, Republic of North Macedonia
| | | | - Stojan Bajraktarov
- Faculty of Medicine, Ss. Cyril and Methodius University, Skopje, Republic of North Macedonia
| | - Marija Raleva
- Faculty of Medicine, Ss. Cyril and Methodius University, Skopje, Republic of North Macedonia
| | - Ashok Roy
- World Psychiatric Association, Geneva, Switzerland; Coventry and Warwickshire Partnership NHS Trust, Birmingham, UK
| | - Muhammad Waqar Azeem
- World Psychiatric Association, Geneva, Switzerland; Department of Psychiatry, Sidra Medicine, Weill Cornell Medicine, Doha, Qatar
| | - Marco Bertelli
- World Psychiatric Association, Geneva, Switzerland; CREA (Centro Ricerca E Ambulatori), Fondazione San Sebastiano, Florence, Italy
| | - Luis Salvador-Carulla
- World Psychiatric Association, Geneva, Switzerland; Health Research Institute, Faculty of Health, University of Canberra, Australia
| | - Afzal Javed
- World Psychiatric Association, Geneva, Switzerland; Warwick Medical School, University of Warwick, UK
| |
Collapse
|
2
|
Nurakysh S, Kurakbayev K, Kosherbaeva L, Tazhiyeva A, Aimakhanova A, Kulkaeva G, Asykbaeva L, Ainabekov M, Fakhradiyev I, Tanabayeva S. Evaluation of the Effectiveness of the Mobile Application on Adherence of Patients With Arterial Hypertension. Acta Inform Med 2022; 30:18-24. [PMID: 35800910 PMCID: PMC9226761 DOI: 10.5455/aim.2022.30.18-24] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2022] [Accepted: 03/02/2022] [Indexed: 12/05/2022] Open
Abstract
Background: An assessment of the level of adherence of patients diagnosed with hypertension to therapy has not been conducted in Central Asia yet. It includes the lack the information on the impact of digital technologies on hypertension management. Objective: The study aimed at the evaluation of the effect of using a mobile application on adherence to therapy in patients with diagnosed arterial hypertension. Methods: A multi-centre randomized controlled study was conducted on 517 patients with diagnosed arterial hypertension (in the out-patient clinic, Almaty, Kazakhstan). Patients were randomly assigned to intervention (IG) and control (CG) groups. IG patients used a mobile application, which allowed creating an individual schedule for taking medications, including visual and audio notifications. The assessment of adherence to antihypertensive treatment was carried out using the Lebanese Medication Adherence Scale-14 (LMAS-14), consisting of 14 items. Data were collected before therapy (T1), 3 months (T2), 6 months (T3) and 12 months (T4) followed the first dose. Adherence was assessed on 101 patients in the CG group and 165 respondents in the IG group. Results: In the period T1 in both groups CG and IG, a moderate adherence to treatment was recorded with indices equal to 35.9 ± 1.2 and 35.9 ± 1.3, respectively (p ≤ 0.05). A decrease in adherence in the CG group was determined after 3 months (35.9 ± 1.2) (p ≤ 0.05) and six months later (36.5 ± 3.2) in comparison with relatively high adherence among respondents in the IG group in periods T2 (39.5 ± 1.2) and T3 (40.5 ± 1.2) (p ≤ 0.001). After 12 months (T4) on the adherence scale in patients who used the mobile application “MyTherapy” (IG), despite a slight decrease in scores, the results were relatively higher (40.3 ± 1.3) compared with the CG group (33.6 ± 1.9) (p ≤ 0.001). Conclusion: The analysis of adherence of patients with primary health care in Almaty (Kazakhstan) with chronic arterial hypertension showed the effectiveness of using the ‘MyTherapy’ mobile application in increasing patient adherence. The obtained data on the positive effect of the use of digital technologies require further research to assess the possibility of wider implementation in healthcare.
Collapse
Affiliation(s)
- Saule Nurakysh
- S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | | | | | - Aigul Tazhiyeva
- S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | - Aizat Aimakhanova
- S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | | | - Lyazzat Asykbaeva
- S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | - Marat Ainabekov
- Kazakhstan’s Medical University “KSPH” LLP, Almaty, Kazakhstan
| | - Ildar Fakhradiyev
- S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | - Shynar Tanabayeva
- S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| |
Collapse
|
3
|
Sadykova L, Abramavičius S, Maimakov T, Berikova E, Kurakbayev K, Carr NT, Padaiga Ž, Naudžiūnas A, Stankevičius E. A retrospective analysis of treatment outcomes of drug-susceptible TB in Kazakhstan, 2013-2016. Medicine (Baltimore) 2019; 98:e16071. [PMID: 31261516 PMCID: PMC6617166 DOI: 10.1097/md.0000000000016071] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Kazakhstan has a high burden of multidrug-resistant tuberculosis (TB). The patient-centered National Program for the treatment and prevention of TB has been implemented in Kazakhstan. The program is aimed at meeting the needs of patients and expansion of the outpatient treatment of TB in the country.The aim of the study was to compare the efficacy of the outpatient and inpatient treatment of drug-susceptible TB.This study was a retrospective cohort study.A total of 36.926 TB cases were included. The majority of patients were treated as inpatients. The socioeconomic factors, sex, age, HIV status, and other diagnostic factors (e.g., sputum smear results, extrapulmonary disease) may serve as risk factors to estimate the likely TB treatment outcome. The outpatient treatment of drug-susceptible TB seems to be a comparable option to the inpatient treatment in terms of efficacy.The socioeconomic factors are the main modifiable risk factors for treatment failure. The outpatient treatment of drug-susceptible TB is safe and effective.
Collapse
Affiliation(s)
- Laura Sadykova
- Asfendiyarov Kazakh National Medical University, Department of Public Heath, Almaty, Kazakhstan
| | - Silvijus Abramavičius
- Institute of Physiology and Pharmacology, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - Talgat Maimakov
- South Kazakhstan Medical Academy, Department of “Pediatrics and Children's Surgery,” Shymkent, Kazakhstan
| | - Elmira Berikova
- National Scientific Center of Phthisiopulmonology, Almaty, Kazakhstan
| | - Kural Kurakbayev
- Department of “Public Health Economics,” Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | | | - Žilvinas Padaiga
- Department of Preventive Medicine, Faculty of Public Health, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - Albinas Naudžiūnas
- Department of Internal Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - Edgaras Stankevičius
- Institute of Physiology and Pharmacology, Lithuanian University of Health Sciences, Kaunas, Lithuania
| |
Collapse
|